Aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage

by Parc Científic de Barcelona (PCB)

With this operation, Aptadel Therapeutics begins a new stage of expansion to drive forward development of its pioneering treatment for Ewing’s sarcoma. The company is preparing a Series A funding ro...

Read more

Aptadel Therapeutics launches with a $2.1M in seed financing

by Professional Newco

Aptadel Therapeutics, a pre-clinical biomedical company focused on developing a RNA-based platform of targeted therapy delivery to treat cancer, has announced the closing of a $2.1M in seed financing....

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

BDO advises Terminal Portuaria Tartessos...

by BDO Financial Advisory

BDO Spain has advised Terminal Portuaria Tartessos, S.A. (TPT) and its...

Photos Stream